Clinical Trials Sponsored by InLight Solutions

Total 1260 results

OHSU Knight Cancer Institute
Oregon Health and Science University; U.S. National Science Foundation

Suspended

Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate

Prostate Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Terminated

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

Metastatic Malignant Neoplasm in the Brain | Primary Brain Neoplasm

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Robert Wood Johnson Foundation

Completed

Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma

Cervical Carcinoma | Human Papillomavirus Infection

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Terminated

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Active, not recruiting

Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Central Nervous System Lymphoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Helsinn Therapeutics (U.S.), Inc

Completed

Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant

Malignant Neoplasm

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Portland VA Medical Center

Completed

Exercise Program Among Lung Cancer Dyads (PEP-LC)

Depression | Quality of Life | Pain | Physical Activity | Lung Cancer | Lung Cancer Symptoms

United States
OHSU Knight Cancer Institute
The Wayne D. Kuni and Joan E. Kuni Foundation

Completed

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); United States Department of Defense

Completed

Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer

Prostate Cancer | Precancerous Condition

United States
University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions and other collaborators

Completed

The Resource Information Program for Parents on Lifestyle and Education (RIPPLE)

Pediatric Obesity

Canada
Medco Health Solutions, Inc.
Mayo Clinic; International Business Machines (IBM); Laboratory Corporation of... and other collaborators

Completed

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer (MHSLabCorp1)

Breast Neoplasms | Tamoxifen

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Recruiting

EMBRACE: Exercising Together

Breast Carcinoma | Prostate Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Recruiting

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Malignant Solid Neoplasm | Lynch Syndrome | Hematopoietic and Lymphoid System Neoplasm | Breast Ductal Carcinoma In Situ | Hereditary Neoplastic Syndrome | BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Taiho Pharmaceutical Co., Ltd.

Recruiting

TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer

Stage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Active, not recruiting

Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC (SMARTER CRC)

Colorectal Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Active, not recruiting

Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN ) (PATTERN)

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Enrolling by invitation

Enhancing Skin Cancer Early Detection and Treatment in Primary Care

Cutaneous Melanoma

United States
OHSU Knight Cancer Institute
Astellas Pharma US, Inc.; Oregon Health and Science University

Active, not recruiting

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

Castration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Completed

EXERCISING TOGETHER for Couples Coping With Cancer

Malignant Solid Neoplasm | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Carcinoma | Colorectal Carcinoma | Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate... and other conditions

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Completed

GET FIT Prostate: A Randomized Controlled Exercise Trial

Prostate Carcinoma

United States
OHSU Knight Cancer Institute
Merck Sharp & Dohme LLC; Oregon Health and Science University

Terminated

Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases

Stage IV Lung Non-Small Cell Cancer AJCC v7 | Lung Carcinoma Metastatic in the Brain

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Completed

Hyperspectral Endoscopy Imaging for the Early Detection of Precancerous Lesions in Average Risk Patients

Patient

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Completed

Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation Therapy

Malignant Neoplasm

United States
OHSU Knight Cancer Institute
Radiological Society of North America; Medical Research Foundation, Oregon

Terminated

Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response

Head and Neck Cancer

United States
Grupo Español de Investigación en Cáncer de Ovario
Apices Soluciones S.L.; TESARO/GSK

Active, not recruiting

TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation (ATOMICC) (ATOMICC)

Cervical Cancer | Advanced Cancer

Spain, Turkey
Fundacion CRIS de Investigación para Vencer el...
Bayer; Pfizer; Apices Soluciones S.L.

Completed

Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer. (ROGABREAST)

Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Metastatic

Spain
Icahn School of Medicine at Mount Sinai
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Metabolic...

Not yet recruiting

High Fructose Diet, the Gut Microbiome, and Metabolic Health

Obesity | Type 2 Diabetes | MASLD

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
National Cancer Institute (NCI); GE Healthcare; Siemens Medical Solutions

Completed

Contrast Ultrasound Detection of Sentinel Lymph Nodes

Breast Cancer

United States
Louisiana State University, Baton Rouge
U.S. Highbush Blueberry Council; Louisiana Health Care Practitioners, LLC; Collective... and other collaborators

Completed

Effect of Whole Blueberry Powder Consumption on Depression in a Central Louisiana Population

Depression | Inflammation | Depression, Anxiety

United States
Fundacion CRIS de Investigación para Vencer el...
GlaxoSmithKline; Apices Soluciones S.L.; Ipsen

Active, not recruiting

Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA) (NICARAGUA)

Urothelial Cancer

Spain
Grupo Español de Tumores Huérfanos e Infrecuentes
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study (GREKO III)

Ovarian Cancer

Spain
CHAD

Terminated

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) (START-Portugal)

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Portugal
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Recruiting

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced and Incurable Solid Tumors

Advanced Malignant Solid Neoplasm

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; American Cancer Society, Inc.

Recruiting

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool (iDECIDE)

Lung Carcinoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; American Cancer Society, Inc.

Recruiting

Pain Management for Head and Neck Cancer Survivors

Head and Neck Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Active, not recruiting

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

Glioblastoma

United States
OHSU Knight Cancer Institute
Janssen Scientific Affairs, LLC; Oregon Health and Science University

Active, not recruiting

Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate Carcinoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Robert Wood Johnson Foundation

Completed

Telehealth & HPV Self-Collection

Gynecologic Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Completed

Progressive Resistance Training for the Improvement of Physical Function

Sarcoma

United States
Maimónides Biomedical Research Institute of Córdoba
Dynamic Solutions; Faes Farma, S.A.; Junta de Andalucía - Consejería de Salud...

Completed

Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome (COVIDIOL)

SARS-CoV 2 | COVID19 | Cytokine Storm | Cytokine Release Syndrome | SARS (Severe Acute Respiratory Syndrome)

Spain
Medicines for Malaria Venture
Sanaria Inc.; ICON Clinical Research; University of Cape Town; Datamap; PrimeVigilance... and other collaborators

Withdrawn

Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model

Malaria,Falciparum

Germany
OHSU Knight Cancer Institute
Genentech, Inc.; Oregon Health and Science University; Taiho Oncology, Inc.

Recruiting

Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid Leukemia

Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States
Emory University
Abbott Medical Devices; Medtronic Vascular; Light Lab Imaging, Inc.

Withdrawn

Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Therapy After Drug Eluting Stent Placement (FDI-DAPT-ZES)

Coronary Artery Disease
University of Southern California
Center for Effective Global Action (CEGA); Median Insights and Research, India

Not yet recruiting

Parental Misperceptions on Child Nutrition in India

Child Malnutrition

India
National Institute of Allergy and Infectious Diseases...
University of Minnesota; International Network for Strategic Initiatives in...

Completed

Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza

Influenza A | Influenza B

United States, Australia, Denmark, United Kingdom
Société des Produits Nestlé (SPN)
Veeva Systems; SAS Institute; BGI-research; Cognizant Technology Solutions AG; Tianjin...

Active, not recruiting

Nutrition, Microbiome and Bone Health During Early Life Related to Health (Bamboo)

Healthy

China
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR); Greybox Solutions Inc.

Completed

HIP Mobile: A Community-based Monitoring, Rehabilitation and Learning e-System for Patients Following a Fracture

Hip Fractures

Canada
Columbia University
National Institute on Drug Abuse (NIDA); Center for Court Innovation; Bronx Community... and other collaborators

Completed

The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders (Project WORTH)

HIV | Sexually Transmitted Infections

United States
Brian Druker
AbbVie; Oregon Health and Science University; Incyte Corporation

Active, not recruiting

Ruxolitinib and Venetoclax in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States
Alexey Danilov, MD
Gilead Sciences; Oregon Health and Science University

Completed

Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

Anemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Hairy Cell Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Grade 1 Follicular... and other conditions

United States

Clinical Trials Sponsored by InLight Solutions

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations